BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25468944)

  • 1. The effect of metformin on glucose homeostasis during moderate exercise.
    Hansen M; Palsøe MK; Helge JW; Dela F
    Diabetes Care; 2015 Feb; 38(2):293-301. PubMed ID: 25468944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
    Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
    Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
    Cunha MR; Silva ME; Machado HA; Fukui RT; Correia MR; Santos RF; Wajchenberg BL; Rocha DM; Rondon MU; Negrão CE; Ursich MJ
    Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise improves metformin 72-h glucose control by reducing the frequency of hyperglycemic peaks.
    Ortega JF; Morales-Palomo F; Ramirez-Jimenez M; Moreno-Cabañas A; Mora-Rodríguez R
    Acta Diabetol; 2020 Jun; 57(6):715-723. PubMed ID: 32020414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of metformin and glibenclamide on glucose metabolism, counter-regulatory hormones and cardiovascular responses in women with Type 2 diabetes during exercise of moderate intensity.
    Cunha MR; da Silva ME; Machado HA; Fukui RT; Correa MR; Santos RF; Wajchenberg BL; Rondon MU; Negrão CE; Ursich MJ
    Diabet Med; 2007 Jun; 24(6):592-9. PubMed ID: 17381497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and exercise in type 2 diabetes: examining treatment modality interactions.
    Boulé NG; Robert C; Bell GJ; Johnson ST; Bell RC; Lewanczuk RZ; Gabr RQ; Brocks DR
    Diabetes Care; 2011 Jul; 34(7):1469-74. PubMed ID: 21602430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin use associated with lower risk of cancer in patients with diabetes mellitus type 2.
    Kusturica J; Kulo Ćesić A; Gušić E; Maleškić S; Rakanović-Todić M; Šečić D
    Med Glas (Zenica); 2017 Aug; 14(2):176-181. PubMed ID: 28698536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic consequences of acute and chronic empagliflozin administration in treatment-naive and metformin pretreated patients with type 2 diabetes.
    Muscelli E; Astiarraga B; Barsotti E; Mari A; Schliess F; Nosek L; Heise T; Broedl UC; Woerle HJ; Ferrannini E
    Diabetologia; 2016 Apr; 59(4):700-8. PubMed ID: 26704626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
    Mevorach M; Giacca A; Aharon Y; Hawkins M; Shamoon H; Rossetti L
    J Clin Invest; 1998 Aug; 102(4):744-53. PubMed ID: 9710443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes alters metabolic and transcriptional signatures of glucose and amino acid metabolism during exercise and recovery.
    Hansen JS; Zhao X; Irmler M; Liu X; Hoene M; Scheler M; Li Y; Beckers J; Hrabĕ de Angelis M; Häring HU; Pedersen BK; Lehmann R; Xu G; Plomgaard P; Weigert C
    Diabetologia; 2015 Aug; 58(8):1845-54. PubMed ID: 26067360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aerobic exercise with or without metformin on plasma incretins in type 2 diabetes.
    Eshghi SR; Bell GJ; Boulé NG
    Can J Diabetes; 2013 Dec; 37(6):375-80. PubMed ID: 24321717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin does not attenuate the acute insulin-sensitizing effect of a single bout of exercise in individuals with insulin resistance.
    Ortega JF; Hamouti N; Fernández-Elías VE; de Prada MV; Martínez-Vizcaíno V; Mora-Rodríguez R
    Acta Diabetol; 2014 Oct; 51(5):749-55. PubMed ID: 24682492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acute effect of metformin on glucose production in the conscious dog is primarily attributable to inhibition of glycogenolysis.
    Chu CA; Wiernsperger N; Muscato N; Knauf M; Neal DW; Cherrington AD
    Metabolism; 2000 Dec; 49(12):1619-26. PubMed ID: 11145127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and exercise effects on postprandial insulin sensitivity and glucose kinetics in pre-diabetic and diabetic adults.
    Moreno-Cabañas A; Morales-Palomo F; Alvarez-Jimenez L; Mora-Gonzalez D; Ortega JF; Mora-Rodriguez R
    Am J Physiol Endocrinol Metab; 2023 Oct; 325(4):E310-E324. PubMed ID: 37584610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Diabet Med; 2009 Jun; 26(6):649-54. PubMed ID: 19538242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment with ipragliflozin and metformin: a randomized, double-blind, placebo-controlled study in patients with type 2 diabetes mellitus.
    Veltkamp SA; van Dijk J; Collins C; van Bruijnsvoort M; Kadokura T; Smulders RA
    Clin Ther; 2012 Aug; 34(8):1761-71. PubMed ID: 22795925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.